The results revealed no marked associations between the Zic1 promoter methylation rate and the clinical parameters, including tumor size, differentiation grade, lymph node status, tumor invasion depth and TNM stage (p > 0.05) (Table 1). The gene discussed is ZIC1; the disease is neoplasm.